학술논문


EBSCO Discovery Service
발행년
-
(예 : 2010-2015)
전자자료 공정이용 안내

우리 대학 도서관에서 구독·제공하는 모든 전자자료(데이터베이스, 전자저널, 전자책 등)는 국내외 저작권법과 출판사와의 라이선스 계약에 따라 엄격하게 보호를 받고 있습니다.
전자자료의 비정상적 이용은 출판사로부터의 경고, 서비스 차단, 손해배상 청구 등 학교 전체에 심각한 불이익을 초래할 수 있으므로, 아래의 공정이용 지침을 반드시 준수해 주시기 바랍니다.

공정이용 지침
  • 전자자료는 개인의 학습·교육·연구 목적의 비영리적 사용에 한하여 이용할 수 있습니다.
  • 합리적인 수준의 다운로드 및 출력만 허용됩니다. (일반적으로 동일 PC에서 동일 출판사의 논문을 1일 30건 이하 다운로드할 것을 권장하며, 출판사별 기준에 따라 다를 수 있습니다.)
  • 출판사에서 제공한 논문의 URL을 수업 관련 웹사이트에 게재할 수 있으나, 출판사 원문 파일 자체를 복제·배포해서는 안 됩니다.
  • 본인의 ID/PW를 타인에게 제공하지 말고, 도용되지 않도록 철저히 관리해 주시기 바랍니다.
불공정 이용 사례
  • 전자적·기계적 수단(다운로딩 프로그램, 웹 크롤러, 로봇, 매크로, RPA 등)을 이용한 대량 다운로드
  • 동일 컴퓨터 또는 동일 IP에서 단시간 내 다수의 원문을 집중적으로 다운로드하거나, 전권(whole issue) 다운로드
  • 저장·출력한 자료를 타인에게 배포하거나 개인 블로그·웹하드 등에 업로드
  • 상업적·영리적 목적으로 자료를 전송·복제·활용
  • ID/PW를 타인에게 양도하거나 타인 계정을 도용하여 이용
  • EndNote, Mendeley 등 서지관리 프로그램의 Find Full Text 기능을 이용한 대량 다운로드
  • 출판사 콘텐츠를 생성형 AI 시스템에서 활용하는 행위(업로드, 개발, 학습, 프로그래밍, 개선 또는 강화 등)
위반 시 제재
  • 출판사에 의한 해당 IP 또는 기관 전체 접속 차단
  • 출판사 배상 요구 시 위반자 개인이 배상 책임 부담
'학술논문' 에서 검색결과 9,065건 | 목록 1~20
Academic Journal
Fischer, Fabian JorgChave, JeromeZanne, AmyJucker, TommasoFajardo, AlexFayolle, AdelineDe Lima, Renato Augusto FerreiraVieilledent, GhislainBeeckman, HansHubau, WannesDe Mil, TomWallenus, DanielAldana, Ana MariaAlvarez-davila, EstebanAlves, Luciana F.Apgaua, Deborah M. G.Arcanjo, FatimaBastin, Jean-francoisBilous, AndriiBirnbaum, PhilippeBlyshchyk, VolodymyrBorah, JoliBoukili, VanessaCamarero, J. JulioCasas, LuisaCazzolla Gatti, RobertoChambers, Jeffrey Q.Fabiano, Ezequiel ChimbioputoChoat, BrendanConti, GeorginaCornwell, WillDar, Javid AhmadDas, Ashesh KumarDobler, MagnusDougabka, DaoEdwards, David P.Evans, RobertFalster, DanielFearnside, PhilipFlores, OlivierFyllas, NikolaosGerard, JeanGoodman, Rosa, 1983; Guibal, DanielHenao-diaz, L. FranciscoHerve, VincentHietz, PeterHomeier, JurgenIbanez, ThomasIlic, JugoJansen, StevenKalita, Rinku MoniKenzo, TanakaKindermann, LianaKothandaraman, SubashreeKotowska, MartynaKubota, YasuhiroLangbour, PatrickLawson, JamesDe Lima, Andre Luiz AlvesLink, Roman MathiasLinstadter, AnjaLopez, RosanaMacinnis-ng, CateMagnago, Luiz Fernando S.Martin, Adam R.Matheny, Ashley M.Mccarthy, James K.Nath, Arun JyotiNelson, Bruce WalkerNjana, MarcoNogueira, Euler MeloOliveira, AlexandreOliveira, RafaelOlson, MarkOnoda, YusukePaul, KerynPiotto, DanielRadtke, PhilRazafindratsima, OnjaRamananantoandro, TahianaRead, JenniferRichardson, SarahDe La Riva, Enrique G.Rodriguez-reyes, OrisRolim, Samir G.Rolo, VictorRosell, Julieta A.Salguero-gomez, RobertoSantini, Nadia S.Schuldt, BernhardSchwendenmann, LuitgardSellin, ArneStaples, TimothyStevenson, Pablo R.Sundarapandian, SomaiahVan Der Sande, Masha T.Thibaut, BernardTng, David Yue PhinTorezan, Jose Marcelo DominguesVillanueva, BorisWeiskittel, AaronWells, JessieWright, S. Joseph
New Phytologist.
eBook
Report
Biosimilars of Rituximab in ANCA-associated Vasculitis Compared to the Originator (BRAVO): a CanVasc Multicentre Study
Stone JH, Merkel PA, Spiera R, Seo P, Langford CA, Hoffman GS, Kallenberg CG, St Clair EW, Turkiewicz A, Tchao NK, Webber L, Ding L, Sejismundo LP, Mieras K, Weitzenkamp D, Ikle D, Seyfert-Margolis V, Mueller M, Brunetta P, Allen NB, Fervenza FC, Geetha D, Keogh KA, Kissin EY, Monach PA, Peikert T, Stegeman C, Ytterberg SR, Specks U; RAVE-ITN Research Group. Rituximab versus cyclophosphamide for ANCA-associated vasculitis. N Engl J Med. 2010 Jul 15;363(3):221-32. doi: 10.1056/NEJMoa0909905.
Guillevin L, Pagnoux C, Karras A, Khouatra C, Aumaitre O, Cohen P, Maurier F, Decaux O, Ninet J, Gobert P, Quemeneur T, Blanchard-Delaunay C, Godmer P, Puechal X, Carron PL, Hatron PY, Limal N, Hamidou M, Ducret M, Daugas E, Papo T, Bonnotte B, Mahr A, Ravaud P, Mouthon L; French Vasculitis Study Group. Rituximab versus azathioprine for maintenance in ANCA-associated vasculitis. N Engl J Med. 2014 Nov 6;371(19):1771-80. doi: 10.1056/NEJMoa1404231.
Mendel A, Ennis D, Go E, Bakowsky V, Baldwin C, Benseler SM, Cabral DA, Carette S, Clements-Baker M, Clifford AH, Cohen Tervaert JW, Cox G, Dehghan N, Dipchand C, Dhindsa N, Famorca L, Fifi-Mah A, Garner S, Girard LP, Lessard C, Liang P, Noone D, Makhzoum JP, Milman N, Pineau CA, Reich HN, Rheaume M, Robinson DB, Rumsey DG, Towheed TE, Trudeau J, Twilt M, Yacyshyn E, Yeung RSM, Barra LB, Khalidi N, Pagnoux C. CanVasc Consensus Recommendations for the Management of Antineutrophil Cytoplasm Antibody-associated Vasculitis: 2020 Update. J Rheumatol. 2021 Apr;48(4):555-566. doi: 10.3899/jrheum.200721. Epub 2020 Sep 15.
Smolen JS, Cohen SB, Tony HP, Scheinberg M, Kivitz A, Balanescu A, Gomez-Reino J, Cen L, Zhu P, Shisha T. A randomised, double-blind trial to demonstrate bioequivalence of GP2013 and reference rituximab combined with methotrexate in patients with active rheumatoid arthritis. Ann Rheum Dis. 2017 Sep;76(9):1598-1602. doi: 10.1136/annrheumdis-2017-211281. Epub 2017 Jun 21.
Park W, Bozic-Majstorovic L, Milakovic D, Berrocal Kasay A, El-Khouri EC, Irazoque-Palazuelos F, Molina FFC, Shesternya P, Miranda P, Medina-Rodriguez FG, Wiland P, Jeka S, Chavez-Corrales J, Garmish O, Linde T, Rekalov D, Hrycaj P, Krause A, Fomina N, Piura O, Abello-Banfi M, Suh CH, Shim SC, Lee SJ, Lee SY, Kim SH, Yoo DH. Comparison of biosimilar CT-P10 and innovator rituximab in patients with rheumatoid arthritis: a randomized controlled Phase 3 trial. MAbs. 2018 Aug/Sep;10(6):934-943. doi: 10.1080/19420862.2018.1487912. Epub 2018 Jul 16.
Cohen SB, Burgos-Vargas R, Emery P, Jin B, Cronenberger C, Vazquez-Abad MD. Extension Study of PF-05280586, a Potential Rituximab Biosimilar, Versus Rituximab in Subjects With Active Rheumatoid Arthritis. Arthritis Care Res (Hoboken). 2018 Nov;70(11):1598-1606. doi: 10.1002/acr.23586.
Park W, Suh CH, Shim SC, Molina FFC, Jeka S, Medina-Rodriguez FG, Hrycaj P, Wiland P, Lee EY, Shesternya P, Kovalenko V, Myasoutova L, Stanislav M, Radominski S, Lim MJ, Choe JY, Lee SJ, Lee SY, Kim SH, Yoo DH. Efficacy and Safety of Switching from Innovator Rituximab to Biosimilar CT-P10 Compared with Continued Treatment with CT-P10: Results of a 56-Week Open-Label Study in Patients with Rheumatoid Arthritis. BioDrugs. 2017 Aug;31(4):369-377. doi: 10.1007/s40259-017-0233-6.
Kwon HC, Kim MK, Song JJ, Park YB, Lee SW. Rituximab Biosimilar Prevents Poor Outcomes of Microscopic Polyangiitis and Granulomatosis with Polyangiitis as Effectively as Rituximab Originator. Yonsei Med J. 2020 Aug;61(8):712-719. doi: 10.3349/ymj.2020.61.8.712.
Mittal S, Naidu GSRSNK, Jha S, Rathi M, Nada R, Minz RW, Sharma K, Dhir V, Jain S, Sharma A. Experience with similar biologic rituximab in 77 patients of granulomatosis with polyangiitis-a real-life experience. Clin Rheumatol. 2021 Feb;40(2):645-651. doi: 10.1007/s10067-020-05261-7. Epub 2020 Jul 12.
Loarce-Martos J, Garcia-Fernandez A, Lopez-Gutierrez F, Garcia-Garcia V, Calvo-Sanz L, Del Bosque-Granero I, Teran-Tinedo MA, Boteanu A, Bachiller-Corral J, Vazquez-Diaz M. High rates of severe disease and death due to SARS-CoV-2 infection in rheumatic disease patients treated with rituximab: a descriptive study. Rheumatol Int. 2020 Dec;40(12):2015-2021. doi: 10.1007/s00296-020-04699-x. Epub 2020 Sep 18.
FAI2R /SFR/SNFMI/SOFREMIP/CRI/IMIDIATE consortium and contributors. Severity of COVID-19 and survival in patients with rheumatic and inflammatory diseases: data from the French RMD COVID-19 cohort of 694 patients. Ann Rheum Dis. 2021 Apr;80(4):527-538. doi: 10.1136/annrheumdis-2020-218310. Epub 2020 Dec 2.
Strangfeld A, Schafer M, Gianfrancesco MA, Lawson-Tovey S, Liew JW, Ljung L, Mateus EF, Richez C, Santos MJ, Schmajuk G, Scire CA, Sirotich E, Sparks JA, Sufka P, Thomas T, Trupin L, Wallace ZS, Al-Adely S, Bachiller-Corral J, Bhana S, Cacoub P, Carmona L, Costello R, Costello W, Gossec L, Grainger R, Hachulla E, Hasseli R, Hausmann JS, Hyrich KL, Izadi Z, Jacobsohn L, Katz P, Kearsley-Fleet L, Robinson PC, Yazdany J, Machado PM; COVID-19 Global Rheumatology Alliance. Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry. Ann Rheum Dis. 2021 Jul;80(7):930-942. doi: 10.1136/annrheumdis-2020-219498. Epub 2021 Jan 27.
Rondaan C, Furer V, Heijstek MW, Agmon-Levin N, Bijl M, Breedveld FC, D'Amelio R, Dougados M, Kapetanovic MC, van Laar JM, Ladefoged de Thurah A, Landewe R, Molto A, Muller-Ladner U, Schreiber K, Smolar L, Walker J, Warnatz K, Wulffraat NM, van Assen S, Elkayam O. Efficacy, immunogenicity and safety of vaccination in adult patients with autoimmune inflammatory rheumatic diseases: a systematic literature review for the 2019 update of EULAR recommendations. RMD Open. 2019 Sep 9;5(2):e001035. doi: 10.1136/rmdopen-2019-001035. eCollection 2019.
Report
Beta-Blocker Therapy Versus Standard Care in Patients With Septic Shock: A Pilot Randomized Controlled Trial Utilizing Predictive Enrichment With Point-of-Care Ultrasound
McChesney C, Orozco N, Fiorini K, Wong MYS, Slessarev M, Prager R, Kao R, Leligdowicz A, Sharif S, Lewis K, Rochwerg B, Honarmand K, Ball IM, Arntfield R, Houlton R, VanNynatten L, Basmaji J. Impact of Short-Acting Beta-Blockers on the Outcomes of Patients With Septic Shock: A Systematic Review and Meta-Analysis. Crit Care Med. 2025 May 1;53(5):e1125-e1139. doi: 10.1097/CCM.0000000000006604. Epub 2025 Feb 26.
Academic Journal
Allentoft, Morten E.Sikora, MartinRefoyo-Martínez, AlbaIrving-Pease, Evan K.Fischer, AndersBarrie, WilliamIngason, AndrésStenderup, JesperSjögren, Karl GöranPearson, AliceSousa da Mota, BárbaraSchulz Paulsson, BettinaHalgren, AlmaMacleod, RuairidhJørkov, Marie Louise SchjellerupDemeter, FabriceSørensen, LasseNielsen, Poul OttoHenriksen, Rasmus A.Vimala, TharsikaMcColl, HughMargaryan, AshotIlardo, MelissaVaughn, AndrewFischer Mortensen, MortenNielsen, Anne BirgitteUlfeldt Hede, MikkelJohannsen, Niels NørkjærRasmussen, PeterVinner, LasseRenaud, GabrielStern, AaronJensen, Theis Zetner TrolleScorrano, GabrieleSchroeder, HannesLysdahl, PerRamsøe, Abigail DaisySkorobogatov, AndreiSchork, Andrew JosephRosengren, AndersRuter, AnthonyOutram, AlanTimoshenko, Aleksey A.Buzhilova, AlexandraCoppa, AlfredoZubova, AlisaSilva, Ana MariaHansen, Anders J.Gromov, AndreyLogvin, AndreyGotfredsen, Anne BirgitteHenning Nielsen, BjarneGonzález-Rabanal, BorjaLalueza-Fox, CarlesMcKenzie, Catriona J.Gaunitz, CharleenBlasco, ConcepciónLiesau, CorinaMartinez-Labarga, CristinaPozdnyakov, Dmitri V.Cuenca-Solana, DavidLordkipanidze, David O.En’shin, DmitriSalazar-García, Domingo C.Price, T. DouglasBorić, DušanKostyleva, ElenaVeselovskaya, Elizaveta V.Usmanova, Emma R.Cappellini, EnricoBrinch Petersen, ErikKannegaard, EsbenRadina, FrancescaEylem Yediay, FulyaDuday, HenriGutiérrez-Zugasti, IgorMerts, IlyaPotekhina, InnaShevnina, IrinaAltinkaya, IsinGuilaine, JeanHansen, JesperAura Tortosa, Joan EmiliZilhão, JoãoVega, JorgeBuck Pedersen, KristofferTunia, KrzysztofZhao, LeiMylnikova, Liudmila N.Larsson, LarsMetz, LaureYepiskoposyan, LevonPedersen, LisbethSarti, LuciaOrlando, LudovicSlimak, LudovicKlassen, LutzBlank, MalouGonzález-Morales, ManuelSilvestrini, MaraVretemark, MariaNesterova, Marina S.Rykun, MarinaRolfo, Mario FedericoSzmyt, MarzenaPrzybyła, MarcinCalattini, MauroSablin, MikhailDobisíková, MilušeMeldgaard, MortenJohansen, MortenBerezina, NataliaCard, NickSaveliev, Nikolai A.Poshekhonova, OlgaRickards, OlgaLozovskaya, Olga V.Gábor, OlivérUldum, Otto ChristianAurino, PaolaKosintsev, PavelCourtaud, PatriceRíos, PatriciaMortensen, PederLotz, PerPersson, PerBangsgaard, Pernillede Barros Damgaard, PeterVang Petersen, PeterMartinez, Pilar PrietoWłodarczak, PiotrSmolyaninov, Roman V.Maring, RikkeMenduiña, RobertoBadalyan, RubenIversen, RuneTurin, RuslanVasilyev, SergeyWåhlin, SidselBorutskaya, SvetlanaSkochina, SvetlanaSørensen, Søren AnkerAndersen, Søren H.Jørgensen, ThomasSerikov, Yuri B.Molodin, Vyacheslav I.Smrcka, VaclavMerts, VictorAppadurai, VivekMoiseyev, VyacheslavMagnusson, YvonneKjær, Kurt H.Lynnerup, NielsLawson, Daniel J.Sudmant, Peter H.Rasmussen, SimonKorneliussen, Thorfinn SandDurbin, RichardNielsen, RasmusDelaneau, OlivierWerge, ThomasRacimo, FernandoKristiansen, KristianWillerslev, Eske
Nature. 625(7994):301-311
Report
Active Surveillance or Surgery for Primary Management of Very Low Risk Papillary Thyroid Cancer: How Often Are the Long-term Disease Management Goals Achieved?
Sawka AM, Ghai S, Tomlinson G, Baxter NN, Corsten M, Imran SA, Bissada E, Lebouef R, Audet N, Brassard M, Zhang H, Gupta M, Nichols AC, Morrison D, Johnson-Obeski S, Prisman E, Anderson D, Chandarana SP, Ghaznavi S, Jones J, Gafni A, Matelski JJ, Xu W, Goldstein DP; Canadian Thyroid Cancer Active Surveillance Study Group. A Protocol for a Pan-Canadian Prospective Observational Study on Active Surveillance or Surgery for Very Low Risk Papillary Thyroid Cancer. Front Endocrinol (Lausanne). 2021 Jun 10;12:686996. doi: 10.3389/fendo.2021.686996. eCollection 2021.
검색 결과 제한하기
제한된 항목
[검색어] Lawson, Joseph
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어